https://www.selleckchem.com/pr....oducts/rituximab.htm
Glucose increased postprandial by 11.4% in the exposed group, compared with 15.7% in the other exposure group (p 0.05), which remained significant after adjusting for confounders (- 4.7%; 95% confidence interval - 9.3%, - 0.01%). Responses to the prandial challenges for the other biomarkers did not differ by intervention group (all p 0.05). Early life exposure to improved nutrition was associated with a more favorable postprandial glucose response in this population. We did not observe a difference in overall cardiometabolic